Compare — Georgia Financials

panel 2026-09-21Ask

Pooled trend

5 companies

Aggregate by year

GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series

Metric	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	22,161	17,403	17,163	19,685	7,503	10,113	5,132
EBITDA	377	398	1,376	2,224	557	942	356
Net profit	353	311	1,338	2,030	454	775	256
Total assets	2,908	2,971	5,903	8,310	7,934	8,319	5,648
n (companies reporting)	3	4	5	4	4	4	3

Per-company contribution by year

XLSX

GEL, thousands

Company	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Med Treideri	2,533	2,518	2,381	2,767	2,633	2,262	1,732
Pulparmi	16,403	12,322	8,385	5,882	0	3,653	1,729
NS Georgia	—	0	4,557	7,057	2,694	2,369	1,670
Maksparma	3,225	2,563	1,840	—	—	—	—
Anshen Pharma	—	—	0	3,979	2,176	1,830	—

Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.

Peer coverage varies by year — FY2018–FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.

Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.